Opto Circuits Ltd Announces Unaudited Standalone and Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
January 30, 2018 at 06:01 am
Share
Opto Circuits (India) Ltd. announced unaudited standalone and consolidated earnings results for the third quarter and first nine months ended December 31, 2017. For the quarter, on standalone basis, the company announced income from operations was INR 193.983 million compared to INR 122.963 million a year ago. Profit before exceptional items and tax was INR 39.594 million compared to loss of INR 31.106 million a year ago. Profit before tax was INR 39.594 million compared to loss of INR 435.406 million a year ago. Profit after tax for the period from continuing operations was INR 39.594 million compared to loss of INR 435.406 million a year ago. Total comprehensive income for the period and other comprehensive income for the period was INR 39.594 million compared to loss of INR 435.406 million a year ago. Basic and diluted earnings per share was INR 0.14 compared to loss of INR 1.80 a year ago.
For the nine months, on standalone basis, the company announced income from operations was INR 388.653 million compared to INR 407.459 million a year ago. Profit before exceptional items and tax was INR 350.339 million compared to INR 2,144.690 million a year ago. Profit before tax was INR 39.110 million compared to loss of INR 1,736.995 million a year ago. Profit after tax for the period from continuing operations was INR 39.110 million compared to loss of INR 2,907.480 million a year ago. Total comprehensive income for the period and other comprehensive income for the period was INR 39.110 million compared to loss of INR 2,907.480 million a year ago. Basic and diluted earnings per share was INR 0.14 compared to loss of INR 12.00 a year ago.
For the quarter, on consolidated basis, the company announced income from operations was INR 586.809 million compared to INR 660.494 million a year ago. Profit before exceptional items and tax was INR 82.437 million compared to INR 100.600 million a year ago. Profit before tax was INR 82.437 million compared to loss of INR 351.190 million a year ago. Profit after tax for the period from continuing operations was INR 80.501 million compared to loss of INR 352.087 million a year ago. Total comprehensive income for the period and other comprehensive income for the period was INR 80.501 million compared to loss of INR 352.087 million a year ago. Basic and diluted earnings per share was INR 0.29 compared to loss of INR 1.45 a year ago.
For the nine months, on consolidated basis, the company announced income from operations was INR 1,619.370 million compared to INR 1,641.881 million a year ago. Profit before exceptional items and tax was INR 223.029 million compared to loss of INR 1,734.434 million a year ago. Profit before tax was INR 195.407 million compared to loss of INR 2,952.410 million a year ago. Profit after tax for the period from continuing operations was INR 187.373 million compared to loss of INR 2,959.245 million a year ago. Total comprehensive income for the period and other comprehensive income for the period was INR 187.373 million compared to loss of INR 2,959.245 million a year ago. Basic and diluted earnings per share was INR 0.63 compared to loss of INR 12.22 a year ago.
Opto Circuits (India) Limited is an India-based global medical devices and technology company. The Company and its subsidiaries are engaged in the design, development, manufacture, marketing and distribution of a range of medical products that are used by primary, secondary and tertiary healthcare establishments, as well as in public access facilities, such as fire stations and policy offices in over 150 countries. It specializes in vital signs monitoring, emergency cardiac care, vascular treatments and sensing technologies. Its interventional products include stents, balloons and arteriovenous shunts used for the treatment of coronary and peripheral arterial diseases, as well as catheters and implants. Its products include automated patient monitoring devices and services, vital signs monitors, pulse oximeters, and peripheral artery disease diagnostic equipment. It also sells a range of related products and consumables and offers a portfolio of related training and support services.